ClearBridge Investments
LAB icon

ClearBridge Investments’s Standard BioTools LAB Stock Holding History

ClearBridge Investments’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-23,710
Closed -$191K – 1076
2016
Q1 		$191K Sell
23,710
-290
-1% -$2.09K ﹤0.01% 785
2015
Q4 		$259K Hold
24,000
– – ﹤0.01% 808
2015
Q3 		$195K Buy
+24,000
New +$378K ﹤0.01% 857

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ClearBridge Investments's LAB Position: Q2 2016 in Review

ClearBridge Investments sold out of Standard BioTools (LAB) in Q2 2016, closing a stake of 23,710 shares — an estimated $191K sold.

ClearBridge Investments first reported a position in LAB in Q3 2015 and held it in 3 quarters. The position peaked at $259K in Q4 2015. 97 funds tracked by Wall St. Rank hold LAB as of Q2 2016.

  • ClearBridge Investments reported no remaining Standard BioTools position as of Q2 2016 after selling out during the quarter.
  • ClearBridge Investments sold 23,710 Standard BioTools shares in Q2 2016, an estimated $191K.
  • ClearBridge Investments first reported a position in Standard BioTools in Q3 2015 and held it in 3 quarters.
  • ClearBridge Investments's Standard BioTools position peaked at $259K in Q4 2015.
  • 97 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2016.

Based on ClearBridge Investments's 13F filing for Q2 2016, filed 15 Aug 2016.